Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 70,000 shares at $116.38 ($8.1M) on 2015-08-17, disclosed to the SEC on 2015-08-18.
Scheduled sale ($8.1M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.70 | 22,542 | $2.6M | 32.1% |
| 2 | $116.38 | 47,458 | $5.5M | 67.9% |
| Total | $116.16 avg | 70,000 | $8.1M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |